We use cookies on this website for continuous optimization and improvement. You decide which cookies you allow or reject. You can change your decision at any time in the cookie settings. For more information, please see our privacy policy Necessary cookies Statistics cookies SAVE PREFERENCES ACCEPT ALL COOKIES EN DE MENU MorphoSys US Groundbreaking Previous Next Latest news 10/11/2021 MorphoSys AG Reports First Nine Months and Third Quarter 2021 Results READ MEDIA RELEASE 09/11/2021 MorphoSys Announces Departure of Roland Wandeler READ MEDIA RELEASE 04/11/2021 MorphoSys presents interim results from M-PLACE study with felzartamab... READ MEDIA RELEASE View all Careers at MorphoSys OUR CURRENT OPENINGS Principal Biostatistician (gn) Clinical Scientist (gn) in Clinical Development SEE ALL OPENINGS Company calendar DATE TITLE ADD TO CALENDAR 03/15/2021 Year-End Results 2020 05/05/2021 First Quarter Interim Statement 2021 05/19/2021 Annual General Meeting 2021 07/28/2021 Half-Year Report 2021 11/10/2021 Third Quarter Interim Statement 2021 Upcoming conferences WED 01 '21 DEC Evercore ISI 4th Annual HealthconX Conference virtual ADD DATE MON 06 '21 DEC JMP Securities Hematology and Oncology Summit virtual ADD DATE THU-TUE 09-14 '21 DEC American Society of Hematology Atlanta, Georgia, USA ADD DATE THU 09 '21 DEC Berenberg Corporate Conference virtual ADD DATE Stock information © 2021 Morphosys AG Imprint Terms and Conditions Privacy policy General Terms & Conditions of Purchase

This site is intended for US residents. MorphoSys AG Global Website Home Innovative Science About Us Our Commitment to You Careers We are driven to advance care by delivering breakthrough cancer therapies to patients who need them. Our mission is to make exceptional, innovative biopharmaceuticals to improve the lives of patients suffering from serious diseases. Our focus is on cancer. Innovative technologies and smart development strategies are central to our approach. As of July 15, 2021, Constellation Pharmaceuticals is a MorphoSys company. Together, we are committed to delivering breakthrough therapies that bring hope to life. Learn more about MorphoSys’ acquisition of Constellation Pharmaceuticals. Welcome to the MorphoSys US website. This site is intended for US residents. The MorphoSys Global website is intended for non-US residents. Please indicate how you would like to proceed: Stay on MorphoSys US Visit MorphoSys Global Our website uses cookies to improve usability. By using the website, you agree to the Cookie Policy. By clicking on the “Cookie Settings” link, you can adapt the use of cookies according to your preferences. Cookie Settings Accept Cookies